News

Posted: July 26, 2011 | Press

Amsino and Owens & Minor to Form Joint Venture

Amsino Medical Group, a privately held developer and manufacturer of high value healthcare disposables, and Owens & Minor, Inc. (NYSE-OMI), a leading distributor of healthcare products to the U.S. acute-care market, have entered into an agreement to establish a joint venture designed to provide sourcing services for Owens & Minor’s private label brand. Amsino will contribute its sourcing expertise to the new company, which will be distinctly separate from Amsino’s existing contract manufacturing, private label and branded businesses. 

Dr. Richard Lee, Chairman and CEO of Amsino Medical Group, said, “We are proud of our sourcing partnership with Owens and Minor, and I believe the joint venture will contribute significantly to the continued successful growth of MediChoice products through focused quality and supply chain management.”

Posted: July 11, 2011 | Press

Amsino Medical Group Engages MedPro Associates in Sales Collaboration

(Pomona, CA – July, 2011)   Beginning July 1, 2011, MedPro Associates will represent Amsino’s AMSure(R)  and AMSafe(R) brands along with certain private labeled products to non-acute markets in the United States and Canada.   MedPro’s 30 sales professionals will team up with Amsino’s existing sales  organization to provide expanded support for Amsino’s current and prospective customer base.

Amsino has provided high value urology, IV/infusion, enteral feeding, respiratory and surgical products to the nursing home, home care and EMS markets for over 17 years.  Amsino’s presence will  dramatically increase with the addition of MedPro’s tenured organization to the sales effort.

Posted: March 10, 2011 | Press

Dr. Richard Lee Joined Committee of 100

(New York, NY—January, 2011) –Committee of 100, an organization of Chinese American leaders, welcomes five new members including Dr. Richard Y. Lee, Chairman and CEO of Amsino Medical Group.

Founded in 1989 by renowned architect I.M. Pei along with other prominent Chinese Americans, the Committee of 100 is an independent, non-profit membership organization composed of Chinese American leaders in a broad range of professions. Its dual mission is to (1) encourage a stronger relationship between the people of the U.S. and Greater China and (2)encourage the full participation of Chinese Americans in all aspects of American life.

Dr. Richard Lee Awarded “2010 Top 10 News Figures in China’s Economy”

Posted: January 18, 2011 | Press

Dr. Richard Lee Awarded “2010 Top 10 News Figures in China’s Economy”

Beijing, January 18th, 2011, Xinhua News Agency
At the just concluded “2010 Chinese Economic Summit and the 8th Top 10 News Figures Award Ceremony” at the People’s Hall of Beijing, Dr. Richard Y. Lee, Chairman and CEO of Amsino Medical Group was awarded “2010 Top 10 News Figures in China’s Economy” with nine others who made significant contributions to the growth and development of the Chinese economy in 2010. Dr. Richard Lee was recognized for his extraordinary leadership and significant contributions to the advancement of the Chinese medical device industry.

Posted: November 17, 2010 | Press

Amsino will participate Medica 2010 Nov 17 to Nov 20, 2010.

Shanghai, Sep. 30, 2010 - Amsino will participate Medica 2010 from Nov 17 to Nov 20, 2010. The booth number is Hall 6 K25.

MEDICA is the center of attraction for all those involved in the health care industry.  More than 138,000 visitors from well over 100 countries are expected to again obtain information on all the current and future trends in in-patient and out-patient care at this annual event.  With its extensive ancillary program, numerous special events, two major congresses and the largest product display in the industry, MEDICA is the hub of the medical trade.  

Posted: October 15, 2010 | News

Amsino Medical Group Reaches Settlement Agreement with Ivera Medical Corporation

In December 2010, Amsino reached an agreement with Ivera Medical Corporation to amicably settle the litigation between the parties that was filed in the California Superior Court for the County of Los Angeles on October 30, 2009. During the pendency of the suit, Amsino denied and vigorously contested all of the allegations against it.  The parties ultimately came to an agreement to settle the litigation. Although the terms of the settlement are confidential, Amsino is pleased to report that it has resolved the matter in its entirety.

Posted: October 12, 2010 | Press

Amsino will attend CMEF from 12 Oct to 15 Oct, 2010

Shanghai, Sept 30, 2010 - Amsino will attend CMEFin Shenyang, China from 12 Oct to 15 Oct, 2010. The booth number is HE1-A20.

China International Medicinal Equipment Fair (CMEF), founded in 1979, is held twice a year - spring and autumn. After 30 years of continuous innovation and self-improvement, CMEF has become the largest exhibition of medical equipment, related products and services in the Asia-Pacific region.

Posted: September 27, 2010 | News

New Director of Sales & Marketing,Great China SBU on board

Shanghai, August 23, 2010 - Please join me in welcoming our new Director of Sales & Marketing, Great China SBU, Andrew Zhang, who joined Amsino Healthcare(Shanghai) Co., Ltd. on August 23, 2010. This position is a replacement. He will report to Richard Lee, CEO of Amsino Medical Group. 

Andrew received his BS in Medicine from Shanghai Jiao Tong University, and EMBA from China Europe International Business School. Before joining Amsino, he has more than twenty years work experience of sales and marketing in medical field. As to our team increase, it takes more energy for us making efforts to provide much more professional support for our company’s business development. And our Great China SBU will definitely devote to hard more than usual together with our all staffs.

Posted: September 21, 2010 | Press

Amsino has recieved FDA cleanrance of Amsure® 3-Way Hydrophilic Latex Foley Catheter

Shanghai, Sep. 21, 2010 – Amsino Medical Group has recently received FDA cleanrance of Amsure® 3-Way Hydrophilic Latex Foley Catheter for commercial distribution under 510(k)-(k101824). 

“This approval broadens our urological product portfolio, allowing us to offer a complete urological product line so that we can better service our customers in the U.S”, said Gang Chen, Vice President of Quality Assurance and Regulatory Affairs of Amsino Medical Group.

  • Follow Us: